全文获取类型
收费全文 | 26894篇 |
免费 | 1534篇 |
国内免费 | 74篇 |
专业分类
耳鼻咽喉 | 348篇 |
儿科学 | 803篇 |
妇产科学 | 905篇 |
基础医学 | 1678篇 |
口腔科学 | 272篇 |
临床医学 | 1638篇 |
内科学 | 7638篇 |
皮肤病学 | 385篇 |
神经病学 | 2084篇 |
特种医学 | 544篇 |
外科学 | 3886篇 |
综合类 | 793篇 |
现状与发展 | 3篇 |
一般理论 | 2篇 |
预防医学 | 4626篇 |
眼科学 | 511篇 |
药学 | 1114篇 |
1篇 | |
中国医学 | 80篇 |
肿瘤学 | 1191篇 |
出版年
2024年 | 26篇 |
2023年 | 535篇 |
2022年 | 1366篇 |
2021年 | 1517篇 |
2020年 | 1176篇 |
2019年 | 2725篇 |
2018年 | 2851篇 |
2017年 | 1176篇 |
2016年 | 633篇 |
2015年 | 793篇 |
2014年 | 1926篇 |
2013年 | 1773篇 |
2012年 | 1319篇 |
2011年 | 1566篇 |
2010年 | 1259篇 |
2009年 | 982篇 |
2008年 | 962篇 |
2007年 | 974篇 |
2006年 | 768篇 |
2005年 | 566篇 |
2004年 | 411篇 |
2003年 | 325篇 |
2002年 | 290篇 |
2001年 | 187篇 |
2000年 | 181篇 |
1999年 | 130篇 |
1998年 | 137篇 |
1997年 | 126篇 |
1996年 | 109篇 |
1995年 | 86篇 |
1994年 | 81篇 |
1993年 | 80篇 |
1992年 | 41篇 |
1991年 | 48篇 |
1990年 | 31篇 |
1988年 | 36篇 |
1986年 | 23篇 |
1985年 | 141篇 |
1984年 | 175篇 |
1983年 | 141篇 |
1982年 | 134篇 |
1981年 | 129篇 |
1980年 | 92篇 |
1979年 | 89篇 |
1978年 | 68篇 |
1977年 | 57篇 |
1976年 | 59篇 |
1975年 | 57篇 |
1974年 | 55篇 |
1973年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
3.
IntroductionHip displacement is common in cerebral palsy (CP) and is related to the severity of neurological and functional impairment. It is a silent, but progressive disease, and can result in significant morbidity and decreased quality of life, if left untreated. The pathophysiology of hip displacement in CP is a combination of hip flexor-adductor muscle spasticity, abductor muscle weakness, and delayed weight-bearing, resulting in proximal femoral deformities and progressive acetabular dysplasia. Due to a lack of symptoms in the early stages of hip displacement, the diagnosis is easily missed. Awareness of this condition and regular surveillance by clinical examination and serial radiographs of the hips are the key to early diagnosis and treatment.Hip surveillance programmesSeveral population-based studies from around the world have demonstrated that universal hip surveillance in children with CP allows early detection of hip displacement and appropriate early intervention, with a resultant decrease in painful dislocations. Global hip surveillance models are based upon the patients’ age, functional level determined by the Gross Motor Function Classification system (GMFCS), gait classification, standardized clinical exam, and radiographic indices such as the migration percentage (MP), as critical indicators of progressive hip displacement.ConclusionDespite 25 years of evidence showing the efficacy of established hip surveillance programmes, there is poor awareness among healthcare professionals in India about the importance of regular hip surveillance in children with CP. There is a need for professional organizations to develop evidence-based guidelines for hip surveillance which are relevant to the Indian context. 相似文献
4.
5.
6.
7.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
8.
Daniel Schar Pawin Padungtod Nguyen Tung Michael OLeary Wantanee Kalpravidh Filip Claes 《Influenza and other respiratory viruses》2019,13(6):618-621
Among the chief limitations in achieving early detection and control of animal‐origin influenza of pandemic potential in high‐risk livestock populations is the existing lag time between sample collection and diagnostic result. Advances in molecular diagnostics are permitting deployment of affordable, rapid, highly sensitive, and specific point‐of‐capture assays, providing opportunities for targeted surveillance driving containment strategies with potentially compelling returns on investment. Interrupting disease transmission at source holds promise of disrupting cycles of animal‐origin influenza incursion to endemicity and limiting impact on animal production, food security, and public health. Adoption of new point‐of‐capture diagnostics should be undertaken in the context of promoting robust veterinary services systems and parallel support for operationalizing pre‐authorized plans and communication strategies that will ensure that the full potential of these new platforms is realized. 相似文献
9.